Optrascan

OptraSCAN is transforming pathology through affordable scalable AI-powered end-to-end solutions that ensure every lab finds products that fit its requirements- Vision: To democratize digital pathology and enable faster, more accurate, and affordable diagnostics* for better healthcare outcomes worldwide - Mission: To empower every lab by enhancing conventional microscopic diagnosis* with digital pathology and AI-driven solutions, enabling faster, more accurate, and collaborative diagnostics* & healthcare outcomes OS-SiA™ is the world’s first patented scanner technology that scans, indexes, and analyzes simultaneously to provide real-time predictive insights. Our scanners are powered by OS-SiA™. WSI Scanners OS-SiX, OS-Lite, OS-Ultra, and OS-FLi models support 6 to 480 slides, with brightfield, fluorescence and frozen section imaging modalities. Scanning occurs using 3D Z-stacking and our patented Composite Imaging across various specimens. AI Algorithms & Analytics - Real-time quantitative insights through heatmaps, scoring, sorting, flagging, and biomarker assessment - Turnkey analysis of breast cancer (ER, PR, Ki67, HER2), lung cancer (PD-L1, EGFR), p53, prostate cancer, cervical cancer (HSIL, LSIL, ASCUS, ASC-H), tuberculosis - OptraQuant (scan + quantitative solution)- CytoSiA (to scale cervical cancer screening)- Virtual IHC staining as diagnostic* prediction Software Capabilities - IMAGEPath: Image Management System provides secure storage, retrieval, sharing of WSIs; integrates with LIS/HIS workflows - TELEPath: Remote platform for real-time teleconsultations and second opinions - E-Learning: Educational resource to offer training modules, courses, etc. Why OptraSCAN - Deployed in 30+ countries - Scanners + AI algorithms + IMS + report (together/modular)- Scalable, customizable - Cost-effective, accessible - Ensures small footprint *In North America, OptraSCAN products are for Research Use Only (RUO) and not for use in diagnostic procedures.